Skip navigation

News

Business Weeklywww.businessweekly.co.uk


Novogene establishes its first European Genomic Sequencing Center at The Babraham Research Campus in Cambridge, UK

Cambridge, United Kingdom – May 21, 2018: Novogene, a leading global provider of genomic services and solutions, today announced its first genomic sequencing center in Europe. The Novogene UK Genomic Sequencing Center will be established at the Babraham Research Campus in Cambridge in the United Kingdom. The center will provide an important base for Novogene to serve its European customers and contribute to human health across Europe. More »
21 May 2018

Concept Life Sciences ranked in top 20 fastest growing UK pharma companies

PharmaTimes presents Alantra’s Fast 50 ranking of fastest growing, privately-owned pharmaceutical businesses in the UK More »
21 May 2018

Coffee adulteration uncovered using new method

A new, more sensitive method for detecting the difference between arabica and cheaper, lower quality robusta coffee based on using a benchtop NMR spectrometer has been developed at the Quadram Institute on the Norwich Research Park. Testing of samples of different coffees labeled as 100% arabica found around 10% contained robusta, potentially defrauding consumers but also smallholder coffee producers in developing countries. More »
16 May 2018

Humans on a chip – the future for research and drug discovery

Medicines Discovery Catapult, the Centre for Drug Safety Sciences at the University of Liverpool and the NC3Rs combine forces to propel the UK into the race to advance organ on a chip technology More »
15 May 2018

Charles River Laboratories Expands Services for Early Discovery Screening

Charles River Laboratories (CRL) today announced the expansion of its service capabilities in early discovery screening. CRL is the first CRO to offer clients access to Apricot Designs' Dual Arm (ADDA) system for high-throughput ADME to identify potential lead compounds in North America and Europe. More »
15 May 2018

PredictImmune Join the Babraham Research Campus Community

Developer of pioneering tools for guiding treatment options in immune-mediated inflammatory diseases choose Babraham Research Campus as permanent base within the Cambridge Cluster More »
14 May 2018

BRITISH DRUG DEVELOPMENT CONSULTANCY, ARTEMIDA PHARMA, RECEIVES THE QUEEN'S AWARDS FOR ENTERPRISE

Her Majesty The Queen today announced drug development consultancy, Artemida Pharma, as a recipient of the Queen's Award for Enterprise in the International Trade category. More »
14 May 2018

MEDIMMUNE AND CAMBRIDGE NETWORK HOLD FORUM ON BUILDING THE DIGITAL HEALTH ECOSYSTEM IN CAMBRIDGE

MedImmune, the global biologics research and development arm of AstraZeneca, and Cambridge Network recently hosted the first Cambridge Digital Health Forum. The event brought together over 130 delegates from industry and academia to explore how digital technologies could potentially make a significant positive impact on patients with respiratory diseases. More »
11 May 2018

TTP plc and Camena Bioscience Partner to Create Novel Metabolite Analyser

More »
09 May 2018

Astex’s Harren Jhoti made Fellow of the Royal Society

Cambridge, UK - Astex Pharmaceuticals (“Astex”), a pharmaceutical company dedicated to the discovery and development of novel small molecule therapeutics for oncology and diseases of the central nervous system, announced today that Harren Jhoti Ph.D., co-founder of Astex and President and CEO of Astex Pharmaceuticals (UK) has been elected a Fellow of the Royal Society in recognition of his outstanding contribution to drug discovery research and science in general. More »
09 May 2018

<< Previous   Page 1 of 38   Next >>